Observational studyRMD open2022

Efficacy and drug persistence of baricitinib monotherapy is similar to combination therapy in patients with active RA: a prospective observational study.

Sara Bayat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.